The first quarter of 2014 is coming to a close, and it was a slow one for MLP IPOs. The only MLP that debuted in the last three months was�Cypress Energy Partners�(NYSE: CELP), but there are several others in the pipeline. Here is how the IPO landscape looks as we end Q1.
Cypress debuted on Jan. 14 as the first MLP IPO of 2014. It sold 3,750,000 units at $20 per unit. CELP is a growth-oriented MLP providing saltwater disposal and other water and environmental services to US onshore oil and natural gas producers and trucking companies in North Dakota and west Texas. The partnership agreement calls for a minimum quarterly distribution of $0.3875 per unit for each whole quarter, or $1.55 per unit on an annualized basis. At Friday�� closing price of $21.87, that translates into an annualized yield of 7.1 percent.
The next IPO may be Enable Midstream Partners, which was formed in May 2013 as a joint venture by affiliates of CenterPoint Energy, OGE Energy and ArcLight Capital Partners. Enable Midstream Partners filed its S-1 with the Securities and Exchange Commission (SEC) back in November, and the offering had been expected in the first quarter of 2014. An�amended registration form�was filed on Friday.
Hot Trucking Stocks To Buy For 2015: Exterran Holdings Inc. (EXH)
Exterran Holdings, Inc., together with its subsidiaries, provides operations, maintenance, service, and equipment for oil and natural gas production, processing, and transportation applications. The company�s Contract Operations segment offers natural gas compression and production, and processing services, as well as engages in the engineering, procurement, and on site construction of natural gas compression stations and/or crude oil or natural gas production and processing facilities. As of December 31, 2011, this segment provided contract operations services primarily using a fleet of 8,485 natural gas compression units with an aggregate capacity of approximately 3,632,000 horsepower in North America; and a fleet of 1,063 units with an aggregate capacity of approximately 1,260,000 horsepower internationally. Its Aftermarket Services segment sells parts and components; and provides operation, maintenance, overhaul, and reconfiguration services for compression, productio n, treating, and oilfield power generation equipment. The company�s Fabrication segment engages in the design, engineering, installation, fabrication, and sale of natural gas compression units, and accessories and equipment used in the production, treatment, and processing of crude oil and natural gas; provision of engineering, procurement, and fabrication services primarily related to the manufacturing of critical process equipment for refinery and petrochemical facilities; and fabrication of tank farms, and evaporators and brine heaters for desalination plants. Its products include line heaters, oil and natural gas separators, glycol dehydration units, condensate stabilizers, dewpoint control plants, water treatment, mechanical refrigeration and cryogenic plants, and skid-mounted production packages designed for onshore and offshore production facilities. The company was founded in 1990 and is based in Houston, Texas.
Advisors' Opinion:- [By Ryan Lowery]
All natural
An obvious place to start is coal's biggest competitor, natural gas. For a while now, I've been a fan of the natural gas compression company, Exterran Holdings (NYSE: EXH ) , which provides operations, maintenance, service, and equipment for both oil and natural gas production. Exterran's stock has had a steady climb the last couple of years -- it's up over 40% this year alone. The majority of analysts are calling Exterran a hold, but several rate it a buy or even a strong buy. Currently, Exterran is trading in the upper $20 range, and with a price target of $33, it still seems to have some upside. And for those interested in investing in master limited partnerships, Exterran operates an MLP as well, Exterran Partners (NASDAQ: EXLP ) , which has seen a 33% gain in its price this year.
Hot Trucking Stocks To Buy For 2015: ONEOK Partners L.P.(OKS)
ONEOK Partners, L.P. engages in the gathering, processing, storage, and transportation of natural gas in the United States. The company?s Natural Gas Gathering and Processing segment gathers and processes natural gas produced from crude oil and natural gas wells located in the Mid-Continent region; and gathers natural gas in the Williston Basin, which spans portions of Montana and North Dakota, and the Powder River Basin of Wyoming. Its Natural Gas Pipelines segment primarily owns and operates regulated natural gas transmission pipelines, natural gas storage facilities, and natural gas gathering systems for non-processed gas. It also provides interstate natural gas transportation and storage services. This segment?s interstate natural gas pipeline assets transport natural gas through FERC-regulated interstate natural gas pipelines in North Dakota, Minnesota, Wisconsin, Illinois, Indiana, Kentucky, Tennessee, Oklahoma, Texas, and New Mexico. In addition, it transports intra state natural gas through its assets in Oklahoma; and owns underground natural gas storage facilities in Oklahoma, Kansas, and Texas. Its Natural Gas Liquids segment gathers, fractionates, and treats natural gas liquids (NGLs), as well as stores NGL products primarily in Oklahoma, Kansas, and Texas. This segment owns FERC-regulated natural gas liquids gathering and distribution pipelines in Oklahoma, Kansas, Texas, Wyoming, and Colorado; terminal and storage facilities in Missouri, Nebraska, Iowa, and Illinois; and FERC-regulated natural gas liquids distribution and refined petroleum products pipelines in Kansas, Missouri, Nebraska, Iowa, Illinois, and Indiana that connect its Mid-Continent assets with Midwest markets, including Chicago, Illinois. ONEOK Partners GP serves as the general partner of the company. The company was formerly known as Northern Border Partners, L.P. and changed its name to ONEOK Partners, L.P. in May 2006. The company was founded in 1993 and is based in Tulsa, Oklahoma.
Advisors' Opinion:- [By Lauren Pollock]
Oneok Partners LP(OKS) issued guidance for 2014 that surpasses its estimate for the current year, citing growth in natural-gas volumes.
QEP Resources Inc.(QEP) plans to separate its midstream business, QEP Field Services Co., into a separate entity, including its interest in QEP Midstream Partners LP(QEPM).
Best Rising Stocks To Invest In 2015: Bellway PLC (BWY)
Bellway p.l.c. is a United Kingdom-based holding company, owning subsidiary undertakings, which is engaged principally in housebuilding in the United Kingdom. The Company�� subsidiaries include Bellway Homes Limited, Bellway Properties Limited, Bellway (Services) Limited, Litrose Investments Limited, Bellway Financial Services Limited, Bellway Housing Trust Limited and The Victoria Dock Company Limited. Advisors' Opinion:- [By Sofia Horta e Costa]
Bellway Plc (BWY) added 1.4 percent after the homebuilder said reservations in the past four months rose 31 percent as buyers had greater access to mortgages. Elan (ELN) Corp. jumped to a 10-month high in Dublin after Royalty Pharma increased its offer for the Irish drugmaker to as much as $6.7 billion. BT Group increased 3.7 percent as Barclays Plc recommended investors buy shares of the U.K.�� largest fixed-line company.
Hot Trucking Stocks To Buy For 2015: Onconova Therapeutics Inc (ONTX)
Onconova Therapeutics, Inc. (Onconova), incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways, which promote cancer. It has three clinical-stage product candidates and six preclinical programs. Its preclinical pipeline includes six programs, which target kinases, cellular metabolism or division.
Rigosertib
Rigosertib, the Company�� product candidate, is being tested in a range of ongoing Phase-II and Phase-III clinical trials. The Company is conducting a pivotal phase-III trial of rigosertib under a Special Protocol Assessment (SPA), from the United States Food and Drug Administration (FDA), for higher risk myelodysplastic syndromes (MDS). The Company is also evaluating rigosertib in a Phase-III trial for metastatic pancreatic cancer, in two Phase-II trials for transfusion-dependent lower risk MDS, and in a Phase-II trial for head and neck cancers. Rigosertib has been granted orphan drug status for MDS in both the United States and Europe, as well as orphan drug status for pancreatic cancer in the United States. Baxter Healthcare SA (Baxter), a subsidiary of Baxter International Inc., has commercialization rights for rigosertib in Europe and SymBio Pharmaceuticals Limited (SymBio), has commercialization rights in Japan and Korea. Rigosertib is an inhibitor of two cellular signaling pathways: phosphoinositide 3-kinase (PI3K), and polo-like kinase (PLK), both of which are frequently over-active in cancer cells. By inhibiting the PI3K pathway in cancer cells, rigosertib promotes tumor cell apoptosis, or programmed cell death. It is testing both intravenous and oral formulations of rigosertib, referred to as rigosertib IV and rigosertib Oral, in clinical trials.
ON 013105
The Company�� clinical-stage product candidate, ON 013105, is i! n a Phase I trial in patients with relapsed or refractory lymphoma, including an aggressive form of non-Hodgkin's lymphoma identified as mantle cell lymphoma (MCL), and acute lymphoid leukemia (ALL). ON 013105 suppresses the accumulation of cyclin D1 in cancer cells.
Recilisib
The Company�� clinical-stage product candidate, recilisib, is being developed in collaboration with the United States Department of Defense (DoD), for acute radiation syndromes (ARS). The Company has completed four Phase-I trials to evaluate the safety and pharmacokinetics of recilisib in healthy human adult subjects using both subcutaneous and oral formulations, referred to as recilisib SC and recilisib Oral.
Preclinical Programs
The Company�� ON 1231320 is a specific inhibitor of Polo-like Kinase 2 (PLK2), and in preclinical studies, it induced mitotic arrest and reduced tumor burden in mice injected subcutaneously with colon tumor and triple-negative breast cancer cells. The Company�� ON 123300 inhibits the activity of two kinases, cyclin-dependent kinase 4 (CDK4), and AMP-activated protein kinase 5 (ARK5). Its ON 108600 is a dual inhibitor of two growth-regulatory kinases. Cyclin-dependent kinase 9 is over expressed in several cancers, including leukemias and lymphomas. Casein kinase 2 is overexpressed in a range of tumor types. ON 044580 inhibits mutant forms of the two target kinases, including Janus Kinase 2 (JAK2) and imatinib-resistant Bcr-Abl Kinase (Bcr-Abl). Its ON 24 compounds cause tubulin to depolymerize, inducing mitotic arrest in cultured tumor cell lines. Its ON 146040 inhibits the growth of a range of blood cancer cell lines, including Burkitt's lymphoma, MCL, multiple myeloma and chronic myeloid leukemia.
The Company competes with Eisai Inc., Celgene Corporation, Genentech, Inc., Cell Therapeutics, Inc., Cyclacel Pharmaceuticals, Inc., Telik, Inc., Spectrum Pharmaceuticals, Inc., Astex, Array BioPharma Inc., Astellas Pharma, Inc., Threshold! Pharmace! uticals, Inc., Pharmacyclics Inc., Soligenix, Inc., Cellerant Therapeutics, Inc. and Cleveland BioLabs, Inc.
Advisors' Opinion:- [By Roberto Pedone]
One under-$10 clinical-state biopharmaceutical player that's starting to move within range of triggering a big breakout trade is Onconova Therapeutics (ONTX), which focuses on discovering and developing small molecule drug candidates to treat cancer. This stock has been destroyed by the short-sellers so far in 2014, with shares off sharply by 56%.
If you glance at the chart for Onconova Therapeutics, you'll notice that this stock has been trending sideways and consolidating right below its 50-day moving average for the last few weeks. This consolidation pattern is occurring right after shares of ONTX recently spiked sharply higher from its low of $4.10 to its high of $5.52 a share. Shares of ONTX are now trending within range of breaking out of that consolidation pattern and potentially heading higher.
Traders should now look for long-biased trades in ONTX if it manages to break out above its 50-day moving average of $5.09 a share and then once it takes out some more key overhead resistance levels at $5.24 to $5.52 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 203,756 shares. If that breakout triggers soon, then ONTX will set up to re-test or possibly take out its next major overhead resistance levels at $6.27 to $7 a share.
Traders can look to buy ONTX off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $4.75 to right around $4.50 a share. One can also buy ONTX off strength once it starts to take out those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
- [By gurujx]
Onconova Therapeutics Inc (ONTX) Reached the 3-year Low of $4.18
The prices of Onconova Therapeutics Inc (ONTX) shares have declined to close to the 3-year low of $4.18, which is 86.8% off the 3-year high of $31.13.
Hot Trucking Stocks To Buy For 2015: Barclays PLC(BCS)
Barclays PLC provides various financial products and services in Europe, the United States, Africa, and Asia. It offers retail and commercial banking, credit cards, investment banking, wealth management, and investment management services. The company?s products include current account and savings products, Woolwich branded mortgages, unsecured loans, protection products, general insurance, credit cards, Sharia-compliant products, installment finance and commercial property finance, commercial loans, and personal loans. It also offers money transmission, international and private banking, investment management, fiduciary, and brokerage services, as well as payment solutions and mobile banking services. In addition, the company provides fixed income, currency and commodities, foreign exchange, emerging markets, money markets, and credit services; equities, which include cash and equity derivatives and prime services; investment banking products and services that comprise fi nancial advisory, and equity and debt underwriting; and advisory services. It serves individual, commercial, corporate, institutional, retail, and mass affluent customers. The company was formerly known as Barclays Bank Limited and changed its name to Barclays PLC in January 1985. Barclays PLC was founded in 1896 and is headquartered in London, the United Kingdom.
Advisors' Opinion:- [By Eric Volkman]
UBS (NYSE: UBS ) , Barclays (NYSE: BCS ) , JPMorgan Chase's near-eponymous J.P. Morgan, Royal Bank of Canada's (NYSE: RY ) Capital Markets arm, and the Securities wings of Wells Fargo and Deutsche Bank (NYSE: DB ) are the joint book-running managers of the issue.
- [By Andrew Marder]
Monday was busy for Barclays (NYSE: BCS ) . The U.K. makes all kinds of fun demands, and it recently came to light that one of those demands was for much, much more capital than Barclays currently has on hand. When I say "more," I of course mean 拢7 billion more. Yesterday, the bank announced that it would be looking to raise the capital through a new share offering, and today it announced that that offering would be for 拢5.8 billion.�
- [By WWW.DAILYFINANCE.COM]
Ann Summa/Time Life Pictures/Getty ImagesThe Pets.com sock puppet has become synonymous with the dot-com bust. As an investor, you need to be smart about where you're putting your money to work. Investing your hard-earned cash in companies that won't use it well -- or in products that haven't proven themselves -- can quickly come around to bite you. Case in point? These 10 famous examples of investment gone horribly wrong: 1. DeLorean Motor Marty McFly's time-traveling adventures weren't the only juicy story featuring the futuristic DeLorean. The inventor of the car with cool side-opening doors from "Back to the Future was caught on tape during an FBI sting declaring the suitcase of cocaine he planned to sell was as "good as gold." The cocaine, worth $24 million, was John DeLorean's last-ditch attempt to save his floundering company from financial ruin. This (combined with charges of defrauding his partners) lost all trust he had with investors. The firm filed for bankruptcy in 1982. (An unrelated company using the same name services the 9,000 cars made.) 2. The Dutch Tulip Craze In the 1630s, the Dutch were flying high on the flowers recently introduced from Turkey. Tulip bulbs became a highly sought-after commodity, with one bulb going for the equivalent of an entire estate. Many investors got so excited that they sold everything they had to get in on the deal. But, like any craze, tulip mania came to an end. As more people started to grow tulips and prices began to lower, investors raced to sell, resulting in an economic depression that still serves as a warning today. 3. Charles Ponzi The famous swindler, whose name is now synonymous with scams, did his dirty dealings back in the 1920s. Cashing in on people's desire to get rich quick, Charles Ponzi wasn't the first to run a pyramid scheme, but he was the first to get so good at it people took notice. His racket involved enticing investors to buy discounted foreign postal reply coupons, which they coul
- [By Shauna O'Brien]
Nomura Securities reported that it has upgraded financial services company Barclays PLC (BCS) to “Buy.”
The firm has lifted its rating on BCS two notches from “Reduce” to “Buy.” Normura has also raised its price target from 260p to 340p.
Analyst Chintan Joshi commented: “With growth in the developed world likely to continue well into the start of next year, stocks geared to capital markets should see macroeconomic support. Structural issues are an industry feature and Barclays could still come out better relative to peers compared with its current position. We expect 2015 ROTE of c12% and believe Barclays should be valued at a 2014E P/TB of 1x as we look for 1Q14 momentum. We set our ex-rights target price at 340p (cum rights it would be 380p), which puts the stock at a 2015E P/E of 6.4x, which is hardly demanding. Barclays is now our top pick among its IB and UK peers and a preferred way to gain exposure to the current risk rally. We upgrade our rating on Barclays to Buy from Reduce. We believe investors waiting for the infamous J curve may find that it is fairly muted for Barclays on the downside.”
Barclays shares were up 27 cents, or 1.40%, during pre-market trading Monday. The stock is up 11% YTD.
Hot Trucking Stocks To Buy For 2015: Express-1 Expedited Solutions Inc.(XPO)
XPO Logistics, Inc. provides third-party logistics services using a network of relationships with ground, sea, and air carriers in the United States, Mexico, and Canada. It operates in three segments: Express-1, Concert Group Logistics, and Bounce Logistics. The Express-1 segment offers ground expedited surface transportation services for freight. It operates a fleet ranging from cargo vans to semi tractor trailer units. The Concert Group Logistics segment provides domestic and international freight forwarding services through a network of independently owned stations. Its domestic freight forwarding services include air charter, expedites, and time sensitive services, as well as cost sensitive services comprising deferred delivery, less than truckload, and full truck load services; and international freight forwarding services consist of on-board courier and air charters, time sensitive services, less-than-container and full-container-loads, and vessel charters. This segm ent also offers documentation on international shipments, customs clearance and banking, trade show shipment management, time definite and customized product distributions, reverse logistics and on site asset recovery projects, installation coordination, freight optimization, and diversity compliance support services. The Bounce Logistics segment provides premium freight brokerage services for truckload shipments. The company serves approximately 4,000 retail, commercial, manufacturing, and industrial customers through 6 U.S. operations centers and 22 agent locations. It offers its services to the automotive manufacturing, automotive components and supplies, commercial printing, durable goods manufacturing, pharmaceuticals, food and consumer products, and high tech sectors. The company was formerly known as Express-1 Expedited Solutions, Inc. and changed its name to XPO Logistics, Inc. in September 2011. XPO Logistics, Inc. was founded in 1989 and is based in Buchanan, Michi gan.
Advisors' Opinion:- [By Jake L'Ecuyer]
XPO Logistics (NYSE: XPO) shot up 7.06 percent to $30.01 after the company announced its plans to acquire Pacer International (NASDAQ: PACR) in a deal valued at $335 million.
Hot Trucking Stocks To Buy For 2015: Matthews International Corporation(MATW)
Matthews International Corporation designs, manufactures, and markets memorialization products and brand solutions for the cemetery and funeral home industries in the United States, Mexico, Canada, Europe, Australia, and Asia. The company's Bronze segment offers cast bronze memorials and other memorialization products; and cast and etched architectural products, as well as builds mausoleums. Its Casket segment provides wood and metal caskets; and casket components, such as stamped metal parts, metal locking mechanisms for gasketed metal caskets, adjustable beds, interior panels, and plastic ornamental hardware, as well as provides assortment planning and merchandising, and display products to funeral service businesses. The company's Cremation segment offers cremation equipment; cremation caskets; equipment service and supplies; and cremation urns and memorial products, as well as offers environmental systems; crematory operations and management services; and cremation col umbarium and niche units. Its Graphics Imaging segment provides brand management, pre-press services, printing plates, gravure cylinders, steel bases, embossing tools, special purpose machinery, engineering and print process assistance, print production management, digital asset management, content management, and package design services. The company's Marking Products segment offers a range of marking and coding products and related consumables, and industrial automation products for identifying, tracking, and conveying consumer and industrial products, components, and packaging containers. Its Merchandising Solutions segment provides merchandising displays and systems, such as permanent and temporary displays, custom store fixtures, brand concept shops, interactive kiosks, custom packaging, and screen and digitally printed promotional signage; and offers design and engineering services. The company was founded in 1850 and is based in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Dan Caplinger]
The first thing to realize about StoneMor is that arcane and flexible accounting rules make it important to dig beneath its GAAP earnings. Growth throughout the industry has been substantial, as up-and-coming Carriage Services (NYSE: CSV ) continued to stay on pace for double-digit sales growth as it rapidly expands its reach. Even well-established player Matthews International (NASDAQ: MATW ) managed to grow revenue by nearly 14% in the quarter that ended in March, although its earnings fell slightly from the year-ago quarter. Still, StoneMor's sales haven't been able to rise as quickly as its peers, with its previous report including just a 6% gain in revenue.
Hot Trucking Stocks To Buy For 2015: Skullcandy Inc (SKUL)
Skullcandy, Inc., incorporated on May 20, 2005, is a designer, marketer and distributor of performance audio and gaming headphones and other accessory related products under the Skullcandy, Astro Gaming and 2XL by Skullcandy brands. The Company's products are sold and distributed through a variety of channels in the United States and approximately 80 countries worldwide. The Company is engaged in the distribution of headphones in specialty retailers focused on action sports and the youth lifestyle, such as Zumiez, Tilly�� and hundreds of independent snow, skate and surf retailers. It distributes through consumer electronics, mass, sporting goods and mobile phone retailers, such as Best Buy, Target, Dick�� Sporting Goods and AT&T Wireless. Skullcandy products are also sold through its Website.
The Company�� product line include dB Collecti; Mobility Collectio, which targets mobile channel with product features designed to work on cell phones and smartphones, such as the Apple iPhone, and 2XL, which represents traditional sports, motor sports and hip-hop and rock and roll music. The Company sponsors athletes, disc jockeys (DJs), musicians, artists and events within all areas of action sports and the indie and hip-hop music genres. Through its Websites, skullcandy.com, skullcandy.tv, ca.skullcandy.com, eu.skullcandy.com, uk.skullcandy.com, 2xl.com, astrogaming.com, astrogaming.co.uk and astrogaming.fr listen to music by its sponsored artists, read blog updates on events, athletes, DJs, musicians and artists, and shop for Skullcandy and Astro Gaming products.
The Company competes with Sony, JVC, Bose, Beats by Dr. Dre, Nixon, adidas, Incase, Urbanears, Monster Cable Products, Sol Republic, iFrogz,Nike and Sennheiser.
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
Getty Images From a door-to-door selling icon stocking up on blush after a disappointing quarter to several hotel chains checking in with strong occupancy trends, here's a rundown of the week's smartest moves and biggest blunders in the business world. Hotels -- Winners Hoteliers were apparently hopping during the first quarter. Despite the iffy weather and the equally iffy economy, the leading chains reporting this week posted surprisingly robust activity. Revenue per available room is a key metric because it tracks occupancy levels as well as prevailing overnight rates. The industry's doing well when RevPAR is positive, and that's just what we saw with this week's reports. Choice Hotels (CHH), Marriott (MAR), and Hyatt (H) clocked in with RevPAR increases of 5.6 percent, 6.3 percent and 6.5 percent, respectively. Twitter (TWTR) -- Loser Shares of Twitter hit an all-time low this week after the company posted disappointing user growth. Sure, the "all-time low" remark needs to be accompanied by the caveat that Twitter has only been trading publicly for less than six months. It's still a grim milestone for last year's most anticipated debutante. Twitter's revenue growth was fine, propelled by the recent success of its monetization initiatives. Its outlook was upbeat. However, the one thing that haunted investors this week was that Twitter had just 14 million more unique monthly visitors than it had a quarter earlier. That kind of sequential uptick would've impressed at most companies, but Twitter trades at a juicy premium to the market. #Letdown. J.C. Penney (JCP) -- Winner The struggling department store operator isn't out of the woods just yet, but at least one supplier is offering up encouraging insight. PVH (PVH) was presenting at an investor conference in Miami earlier in the week when its CEO offered up an encouraging perspective. "The Penney's business is running on or ahead of plan and given what their sales trends are," said CEO Manny Chirico,
Hot Trucking Stocks To Buy For 2015: DENTSPLY International Inc.(XRAY)
DENTSPLY International Inc. designs, develops, manufactures, and markets dental consumable products, dental laboratory products, and dental specialty products worldwide. The company?s dental consumable products include dental sundries, such as dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment, including high and low speed handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers used in dental offices for the treatment of patients. Its dental laboratory products comprise dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as equipment, such as computer aided machining ceramic systems and porcelain furnaces used in the preparation of dental appliances by dental laboratories. The company?s dental specialty products consist of endodonti c instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, and orthodontic appliances and accessories. Its customers include dentists, dental hygienists, dental assistants, dental laboratories, and dental schools. The company distributes its dental products directly to dental laboratories and dental professionals, as well as through distributors, dealers, and importers. DENTSPLY International Inc. was founded in 1983 and is headquartered in York, Pennsylvania.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap dental stock BIOLASE Inc (NASDAQ: BIOL) surged 17.69% after announcing it had received a license from the Health Canada-Medical Device Bureau to sell its EPIC dental soft-tissue diode laser systems throughout Canada, meaning its worth taking a closer look at the stock along with the performance of mid cap dental stocks like Sirona Dental Systems, Inc (NASDAQ: SIRO), DENTSPLY International Inc (NASDAQ: XRAY) and Align Technology, Inc (NASDAQ: ALGN).
- [By Ben Levisohn]
Shares of Align have surged 24% to $57 at 12:37 p.m. Sirona Dental Systems (SIRO) has risen 0.8% to $69.61, Dentsply International (XRAY) is up 0.1% at $45.44, Integra Lifesciences (IART) has� gained 0.4% to $44.23 and Danaher (DHR) has fallen 0.3% to $72.13.
- [By Sue Chang and William L. Watts]
Dentsply International Inc. (XRAY) �shares rose 3%. The stock was raised to buy from underperform at Bank of America, according to Benzinga.
No comments:
Post a Comment